askin tumor
Showing 1 - 25 of >10,000
Ewing's Sarcoma, Primitive Neuroectodermal Tumor (PNET), Askin's Tumor of the Chest Wall Trial in France, Italy, United States
Completed
- Ewing's Sarcoma
- +3 more
-
Santa Monica, California
- +6 more
Sep 30, 2021
Collecting and Storing Biological Samples From Ewing Sarcoma
Active, not recruiting
- Askin Tumor
- +3 more
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +188 more
Mar 23, 2022
Ewing's Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in New York, Dallas (pbi-shRNA™ EWS/FLI1 Type 1 LPX)
Active, not recruiting
- Ewing's Sarcoma
- +6 more
- pbi-shRNA™ EWS/FLI1 Type 1 LPX
-
New York, New York
- +1 more
Mar 14, 2022
NSCLC (NSCLC) Trial in Baltimore (ROSE (presence of cytotech), NO-ROSE (absence of cytotech))
Enrolling by invitation
- Non-small Cell Lung Cancer (NSCLC)
- ROSE (presence of cytotech)
- NO-ROSE (absence of cytotech)
-
Baltimore, Maryland
- +1 more
Jan 5, 2023
Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Combination 5-azacytidine and nivolumab
- +2 more
- (no location specified)
Dec 7, 2022
Neuronal Insult in Newborns of COVID-19 Positive Mothers.
Not yet recruiting
- COVID-19 Pandemic
- Gene Expression
- (no location specified)
Jan 1, 2022
Ischemia Reperfusion Injury Trial in Philadelphia (Conjugated Estrogen, Normal saline)
Recruiting
- Ischemia Reperfusion Injury
- Conjugated Estrogen
- Normal saline
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 22, 2022
Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)
Recruiting
- Unknown Primary Tumors
- Oropharynx Cancer
- Detection of lesions using fluorescence molecular imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Oct 20, 2023
Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))
Recruiting
- Oncology
- moderate Whole Body Hyperthermia (mWBH)
-
Berlin, GermanyKlinik für Radioonkologie und Strahlentherapie
Apr 6, 2023
Immune Biomarker Study for Salivary Gland Carcinoma
Not yet recruiting
- Salivary Gland Tumor
- Benign Salivary Gland Tumor
- Sampling
-
Erlangen, Bavaria, Germany
- +1 more
Sep 21, 2023
Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)
Recruiting
- Malignant Tumor
- +2 more
- 68Ga-TCR-FAPI PET/CT
-
Beijing, ChinaPeking University Cancer Hospital
Oct 19, 2023
Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)
Not yet recruiting
- Meningioma
- +2 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Aug 21, 2023
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
Effect of Sleep Disorder on the Development of Lung Tumors
Not yet recruiting
- Sleep Disorder, Lung Tumor
- (no location specified)
Feb 24, 2023
Body Composition and Digestive System Cancer Survival
Active, not recruiting
- Digestive System Cancer
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
Solid Tumor Trial in Tianjin (LM103)
Recruiting
- Solid Tumor
- LM103
-
Tianjin, ChinaTianjin Beichen Hospital
Jul 4, 2023
ALDH1A1 Expression in Invasive Mammary Carcinoma
Enrolling by invitation
- Breast Cancer
-
Sohag, EgyptFaculty of Medicine
Nov 12, 2023
Soft Tissue Sarcoma Trial in Toronto (Archival tumor tissue collection and blood draws)
Recruiting
- Soft Tissue Sarcoma
- Archival tumor tissue collection and blood draws
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
HER2 Expressing or Mutated Advanced Malignant Solid Tumors Trial in China (GQ1005)
Recruiting
- HER2 Expressing or Mutated Advanced Malignant Solid Tumors
-
Beijing, Beijing, China
- +19 more
Nov 23, 2023
Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- HER2-Negative Breast Carcinoma
- Biospecimen Collection
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 30, 2023